BharatRohan Reports Zero Deviation in IPO Proceeds Utilization as of Sep'26
Bharatrohan Airborne Innovations Ltd · Others (Uncategorized) · 14 Nov 2026, 1:46 am
BharatRohan Reports Zero Deviation in IPO Proceeds Utilization as of Sep'26 BharatRohan Airborne Innovations Limited reported no deviation in the utilization of IPO proceeds for the half-year ended 30th Sep'26. Out of the planned net issue proceeds of ₹3,979.29 lakhs, the company has utilized ₹2,889.63 lakhs, leaving ₹1,089.66 lakhs unutilized. Working capital requirements (₹1,668.00 lakhs) and general corporate purposes (₹661.48 lakhs) have been fully deployed. For capital expenditure on new equipment, ₹470.62 lakhs has been spent against ₹1,420.62 lakhs planned, while commercial vehicle purchases accounted for ₹89.17 lakhs out of ₹229.19 lakhs allocated.
Original exchange filing (PDF)
More announcements from Bharatrohan Airborne Innovations Ltd
- Earnings Presentation for the Unaudited Financial Results for the Half Year Ended 30th September 2026. · 18 Nov 2026
- Press Release for Unaudited Financial Statement of the Company Half Year ended on 30th September 2026 · 14 Nov 2026
- Intimation of Scheduling Earnings Conference Call for H1 FY27 Financial Results is scheduled on Wednesday i.e 18th November, 2026 · 18 Nov 2026
- Approval of Half Year Financial Statement (Standalone and Consolidated) along with Limited Review Report for Half Year Ended 30th September 2026 · 14 Nov 2026
- Board Members in a Board Meeting held on 13th November 2026 to consider and approve the following agendas 1. Consider and Approve Unaudited Financials Results (Standalone and Consolidated) .... · 14 Nov 2026
- BharatRohan Achieves Technology Milestone in Hyperspectral Imaging for Pharmaceutical Quality Screening; Engaged in Discussions with Regulatory Authority. · 13 Nov 2026
- BharatRohan INC, a step-down subsidiary of the company, proposes fundraising by way of Private Placement in the USA up to USD 5 million. · 11 Nov 2026
- Bharatrohan Airborne Innovations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited .... · 13 Nov 2026
